Back
Bio-Rad Laboratories Vs. Okta Industry Stock Comparison
Sell
45
BIO
Bio-Rad Laboratories
Last Price:
$247.42
Seasonality Move:
-0.22%
Buy
52
OKTA
Okta
Last Price:
$91.10
Seasonality Move:
-4.42%
Sell
45
Bio-Rad Laboratories (BIO)
is a Sell
Is Bio-Rad Laboratories a Buy, Sell or Hold?
-
The current Bio-Rad Laboratories [BIO] share price is $250.81. The Score for BIO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIO Stock Price Chart
What is Bio-Rad Laboratories's stock price today?
-
The Bio-Rad Laboratories share price today is $250.81The current trend is moderately bullish and BIO is experiencing slight selling pressure.
OKTA Stock Price Chart
BIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.74 | Buy |
Relative Strength Index (14 RSI): | 57.58 | Buy |
Chaikin Money Flow: | -87325 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (229.76 - 250.86) | Buy |
Bollinger Bands (100): | (229.95 - 258.85) | Buy |
OKTA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 23.17 | Buy |
Relative Strength Index (14 RSI): | 30.5 | Sell |
Chaikin Money Flow: | 1176455 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (95.78 - 101.12) | Sell |
Bollinger Bands (100): | (95.15 - 115.59) | Sell |
BIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 252.59 | Sell |
20-day SMA: | 243.49 | Buy |
50-day SMA: | 237.49 | Buy |
200-day SMA: | 291.7 | Sell |
8-day EMA: | 251.82 | Sell |
20-day EMA: | 245.56 | Buy |
50-day EMA: | 242.76 | Buy |
200-day EMA: | 275.36 | Sell |
OKTA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 96.16 | Sell |
20-day SMA: | 97.68 | Sell |
50-day SMA: | 107.61 | Sell |
200-day SMA: | 93.2 | Sell |
8-day EMA: | 67.25 | Buy |
20-day EMA: | 37.23 | Buy |
50-day EMA: | 17.18 | Buy |
200-day EMA: | 4.63 | Buy |
Bio-Rad Laboratories Earnings Growth & BIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.57 per share, a decrease this year of $1.56 per share, and an increase next year of $0.71 per share.
Okta Earnings Growth & OKTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.12 per share, an increase this year of $1.29 per share, and an increase next year of $0.51 per share.
Bio-Rad Laboratories Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Okta Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |